Search the Newsreel

Reaffirmed 2026 Guidance and Dividend Policy Could Be A Game Changer For IRADIMED (IRMD)

Panvel (PNVL3): 2T com resultados sólidos

CalciMedica Inc (CALC) Earnings Forecast: Future EPS & Revenue Growth Estimates

The article provides an earnings forecast for CalciMedica Inc (CALC), highlighting analyst ratings, target prices, and historical EPS performance. Analysts currently have a "Buy" consensus for CALC, with a target price of USD 15.50 and a significant upside potential of +1374.72%. The previous quarter's …

MiMedx Group's (NASDAQ:MDXG) Soft Earnings Are Actually Better Than They Appear

MiMedx Group's recent earnings might seem weak, but a deeper analysis reveals a stronger financial position than initially perceived. The company's accrual ratio of -0.36 indicates that its free cash flow significantly exceeded its reported statutory profit, suggesting an understatement of its true earnings …

MiMedx Group Inc (MDXG) Earnings Forecast: Future EPS & Revenue Growth Estimates

The article provides an earnings forecast for MiMedx Group Inc (MDXG), highlighting its current earnings forecast score of 8.00 and an average analyst price target of $12.00. Based on 5 analysts, the stock has a "Buy" rating with a potential upside of 61.29%. Key …

MiniMed Group (NASDAQ: MMED) says General Counsel Courtney Nelson Wills will step down

MiniMed Group (NASDAQ: MMED) announced that its Senior Vice President, General Counsel, and Corporate Secretary, Courtney Nelson Wills, will resign effective September 25, 2026. Ms. Wills notified the company on July 30, 2026, and her departure is due to personal reasons, as she has …

Price to sales forward of Archimedes Tech SPAC Partners II Co. – NASDAQ:ATIIW

This article displays the forward Price to Sales (P/S) ratio for Archimedes Tech SPAC Partners II Co. (NASDAQ: ATIIW). It is a financial data point presented by TradingView, indicating a key valuation metric for the company. The page provides the period, value, and change …

Archimedes Tech SPAC Partners II Co. Revenue Breakdown – BOATS:ATIIU

This article provides financial overview and data for Archimedes Tech SPAC Partners II Co. (ATIIU), accessible through TradingView. It indicates that the market is closed with no recent trades and offers various financial details such as statements, statistics, dividends, earnings, and segment performance. The …

MiniMed Group Inc (NASDAQ:MMED) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Analysts have given MiniMed Group Inc (NASDAQ:MMED) a "Moderate Buy" consensus recommendation, with 13 buy ratings, two holds, and one sell from 16 firms. The average 12-month price target is $21.62, higher than the stock's opening price of $18.05. Despite mixed recent analyst actions …

CalciMedica, Inc. SEC Filing (Aug 3, 2026)

This article reports on CalciMedica, Inc.'s SEC filing, specifically a Notice of Effectiveness for an S-3 form, dated July 31, 2026. The filing indicates a "Neutral" impact and sentiment according to AI analysis. The company's latest news and other recent SEC filings are also …

iRadimed declares $0.20 dividend

* iRadimed (IRMD [https://seekingalpha.com/symbol/IRMD]) declares $0.20/share quarterly dividend [https://seekingalpha.com/pr/20602837-iradimed-corporation-reports-second-quarter-2026-financial-results], in line with previous. * Forward yield [https://seekingalpha.com/symbol/IRMD/dividends/yield?source=news_bullet] 0.88% * Payable Aug. 28; for shareholders of record Aug. 14; ex-div Aug. 14. * See IRMD Dividend Scorecard, Yield Chart, & Dividend Growth. [https://seekingalpha.com/symbol/IRMD/dividends?source=news_bullet] MORE ON …

IRADIMED (IRMD) Stock Drops As 3870 Ramp Cuts Gross Margin

IRADIMED (IRMD) stock dropped 4.6% despite posting Q2 revenue of US$20.5m and non-GAAP EPS of US$0.46. The company experienced a deliberate hit to its gross margin, which compressed from 78% to 74%, as the new 3870 MR intravenous pump moved into a higher volume …

MiMedx Group Number of Employees 2026 | Employee Count & Headcount Data

MiMedx Group (NASDAQ: MDXG) had 799 employees globally as of March 2026, representing a 1.0% decline since 2023. The company is actively hiring, with 40 active job postings in 2026, though new postings are slowing. The workforce is primarily concentrated in the United States, …

CalciMedica Inc (CALC:UR): Stock Price, Quote and News

This page from BNN Bloomberg provides information on CalciMedica Inc (CALC:UR), including its stock price, quote, and related news. It appears to be a company-specific page on a financial news platform, offering resources for investors to track the company's performance and developments. The content …

Renaissance Technologies LLC Has $11.93 Million Stake in MiMedx Group, Inc $MDXG

Renaissance Technologies LLC increased its stake in MiMedx Group, Inc (MDXG) by 22.4% in the first quarter, now holding 3.02 million shares valued at $11.93 million, representing 2.03% of the company. Despite some recent analyst price target reductions and downgrades, the stock maintains a …

IRADIMED CORP Q2 2026: Revenue $20.47M, EPS $0.41— 10-Q Summary

IRADIMED CORP reported its second-quarter 2026 results, showing flat revenue year-over-year at $20.47M, while net income and diluted EPS decreased due to margin pressure from new-product production. Revenue growth was driven by device launches and disposables, with a notable shift in geographic mix as …

Earnings call transcript: IRadimed tops Q2 2026 estimates as 3870 ramp weighs margins

IRadimed anticipates Q3 revenue of $23M-$24.5M as 3870 pump production ramps to over 300 units

Earnings Call Insights: IRadimed (IRMD) Q2 2026 MANAGEMENT VIEW * “This quarter, we embarked on the first general release production of the new 3870 MR IV pump system as planned, targeting... the building of 130 to 135 of these new pumps,” and “achieved our …

IRADIMED: More Than 70% of New Pump Orders Were Four-Pump Setups

IRADIMED (NASDAQ: IRMD) announced its Q2 2026 financial results, reporting $20.5 million in revenue, up 0.5% year-over-year, with GAAP diluted EPS of $0.41 and non-GAAP diluted EPS of $0.46. The company reaffirmed its full-year 2026 guidance, expecting $91.0–$96.0 million in revenue and GAAP EPS …

IRadimed: Q2 Earnings Snapshot

This article provides a Q2 earnings snapshot for IRadimed. The content is concise and directly presents the company's performance for the quarter.

Iradimed reports Q2 revenue $20.5M, EPS $0.41; raises dividend to $0.20 and reaffirms 2026 guidance

Iradimed (IRMD) reported Q2 revenue of $20.5 million and diluted EPS of $0.41, alongside declaring a $0.20 quarterly dividend. The company reaffirmed its Q3 and full-year 2026 revenue and GAAP EPS guidance, anticipating revenue between $91.0M–$96.0M and GAAP EPS of $1.90–$2.05 for the full …

iRadimed (NASDAQ:IRMD) Releases Q3 2026 Earnings Guidance

Iradimed Co earnings beat by $0.02, revenue topped estimates

Renaissance Technologies LLC Sells 15,700 Shares of iRadimed Corporation $IRMD

Renaissance Technologies LLC reduced its stake in iRadimed Corporation by 3.4% during the first quarter, selling 15,700 shares but still retaining 440,712 shares valued at approximately $42.4 million. Despite this sale, institutional investors collectively own 92.34% of the company, and analysts maintain a "Buy" …

Sanara MedTech (SMTI) plans business combination with MiMedx Group to build regenerative leader

Sanara MedTech (SMTI) has announced a proposed business combination with MiMedx Group, Inc., aiming to establish a leading regenerative medicine company focused on surgical and wound care applications. The transaction is expected to close by year-end, pending regulatory and shareholder approvals. Until then, both …

Iradimed earnings on deck as growth momentum faces Q2 test

Iradimed (IRMD) is set to report its second-quarter earnings, with analysts expecting $0.44 earnings per share on $20.35 million in revenue, a sequential decline from Q1. Investors will focus on the performance of its new MRI-compatible IV infusion pump, margin sustainability, and management's reaffirmation …

MiMedx Group Q2 Earnings Call Highlights

MiMedx Group announced its Q2 results and the acquisition of Sanara MedTech for $35 per share, expecting the deal to close by the end of 2026. This acquisition will significantly shift MiMedx's revenue mix towards surgical products, expanding its market opportunity by an estimated …

ETFs Investing in MiMedx Group, Inc. Stocks

This article lists various Exchange Traded Funds (ETFs) that hold shares of MiMedx Group, Inc. (MDXG). It provides a detailed table with each ETF's market value of MDXG holdings, weight in the ETF, issuer, management style, focus, expense ratio, assets under management (AUM), price, …

MiMedx Group (SMTI) details Sanara MedTech buyout and 2027 profit goals

MiMedx Group announced its plan to acquire Sanara MedTech for $35 per share, aiming to combine Sanara's surgical revenue with MiMedx's soft-tissue surgical franchise and achieve at least $20 million in annual cost synergies. Despite a 35% year-over-year net sales drop in Q2 2026 …

Forge Nano and ATII Holdings (ATII) outline SPAC merger, DOE funding and ALD push

Forge Nano and ATII Holdings are proceeding with a SPAC merger, detailing Forge Nano's growth strategy which includes a strategic partnership with Samsung SDI for lithium-ion battery manufacturing and a North Carolina battery facility partly funded by a $100 million Department of Energy grant. …

MiMedx Group (NASDAQ:MDXG) Shares Gap Down on Disappointing Earnings

CalciMedica Inc (CALC) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of CalciMedica Inc (CALC), detailing its support, resistance levels, and various technical indicators. It includes a summary of "Sell," "Neutral," and "Buy" signals based on indicators like MACD, RSI, and moving averages. The analysis suggests a "Neutral" signal …

MiMedx: Q2 Earnings Snapshot

This article provides a brief snapshot of MiMedx's Q2 earnings. No specific financial details or further information about the earnings are included in the provided content.

MiMedx Group to Acquire Sanara MedTech in Merger

MiMedx Group announced its agreement to acquire Sanara MedTech in a cash-and-stock merger, valuing Sanara at $35 per share, representing approximately $350 million in enterprise value and a 46% premium. This acquisition aims to nearly double MiMedx's surgical revenue, enhance profitability, and generate over …

Record Results, New MRI Pump And Dividend Hike Might Change The Case For Investing In IRADIMED (IRMD)

IRADIMED (IRMD) recently reported record 2025 results, strong Q1 2026, and FDA clearance for its upgraded MRidium 3870 MRI IV infusion pump, alongside an increased quarterly dividend. These developments, particularly the new pump expected to drive replacement demand, are highlighted as potentially reshaping the …

Transcript : MiMedx Group, Inc., Q2 2026 Earnings Call, Jul 29, 2026

This article is a transcript of MiMedx Group, Inc.'s Q2 2026 Earnings Call, which took place on July 29, 2026. The content is primarily a message from the operator indicating the start of the conference call. The full transcript is reserved for subscribers.